新潟大学医歯学総合病院は、新潟県新潟市中央区旭町通一番町754番地にある国立大学法人新潟大学の附属大学病院。2014年の患者数は、医科外来402,335名、歯科外来148,418名、医科入院256,156名、歯科入院10,228名である。略称は新潟大学病院または新大病院。

During the past decade, Niigata University Medical & Dental Hospital conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 29 clinical trials were completed, i.e. on average, 42% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 22 clinical trials were completed. i.e. 62.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Niigata University Medical & Dental Hospital" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Pfizer" with 7 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored, "Janssen Pharmaceutical K.K." with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Niigata University Medical & Dental Hospital" #1 collaborator was "NRG Oncology" with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator and "Japan Lung Cancer Society" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Niigata University Medical & Dental Hospital" are "Fallopian Tube Cancer" (4 trials), "Ovarian Cancer" (4 trials), "Heart Failure" (3 trials), "Non-Small Cell Lung Cancer" (3 trials) and "ALS" (2 trials). Many other conditions were trialed in "Niigata University Medical & Dental Hospital" in a lesser frequency.

Most popular intervention types in "Niigata University Medical & Dental Hospital" are "Drug" (81 trials), "Other" (15 trials), "Biological" (7 trials), "Device" (5 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Atezolizumab" (10 trials), "Carboplatin" (9 trials), "Bevacizumab" (6 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Niigata University Medical & Dental Hospital" are 73 trials for "All" genders, 18 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Niigata University Medical & Dental Hospital". undefined are not yet recruiting, 23 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Niigata University Medical & Dental Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Niigata University Medical & Dental Hospital, 4 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".